The global molecular infectious disease testing market size was valued at USD 9.78 billion in 2024. It is expected to grow from USD 11.10 billion in 2025 to USD 34.73 billion by 2034, at a CAGR of 13.5% during 2025–2034. This pace of expansion reflects the increasing prevalence of infectious pathogens, the rising adoption of nucleic acid amplification tests (NAAT), and the growing...